|Mr. David R. Hummel BSc||Chief Exec. Officer and Exec. Director||N/A||N/A||59|
|Ms. Louisa S. Burdett BSc, ACA||Group Fin. Director and Exec. Director||395.04k||N/A||N/A|
|Mr. Timothy J. Cooper BA Hons||Exec. Director of Industrial, Exec. DirectorManaging and Director of Victrex Polymer Solutions Bus.||N/A||N/A||N/A|
|Dr. Martin L. Court BSc (Eng), Ph.D.||Exec. Director Medical, Exec. Director and Managing Director of Invibio Bus.||329.04k||N/A||55|
|Mr. Andrew Hanson||Head of Investor Relations & Communications||N/A||N/A||N/A|
Victrex plc, through its subsidiaries, manufactures and sells polymers worldwide. It operates through two segments, Victrex Polymer Solutions and Invibio Biomaterial Solutions. The company offers VICTREX PEEK polymer materials; and biomaterial solutions for use in spine, dental, trauma, knee, cardiovascular, and orthopedic applications. It serves automotive, aerospace, energy, industrial, electronics, and medical markets. The company was incorporated in 1993 and is headquartered in Thornton Cleveleys, the United Kingdom.
Victrex plc’s ISS Governance QualityScore as of May 1, 2017 is 1. The pillar scores are Audit: 1; Board: 1; Shareholder Rights: 1; Compensation: 3.